AI-powered technology for enhancing oncology decision-making through deep learning imaging.

Tool: Onc.AI
Description: AI-powered technology for enhancing oncology decision-making through deep learning imaging.
Summary: Onc.AI utilizes a comprehensive oncology dataset, including diagnostic imaging, EMR, labs, and genomics, to develop AI models aimed at advancing precision oncology. Their initial focus is on predicting clinical outcomes in metastatic lung cancer, supporting both pharmaceutical clinical development and medical oncologist decision-making. The technology is designed to integrate seamlessly into existing clinical workflows, providing actionable insights to inform treatment strategies.
Category: Precision Medicine
Tags: Predictive Analytics, Cancer Detection, Genomics
Use Cases: Predicting clinical outcomes in metastatic lung cancer to aid in treatment decision-making.; Supporting pharmaceutical clinical development with precise oncology-focused AI models.
Platform: Web
Vendor: Onc.AI
Target Users: Clinician
Pricing: not for sale
Regulatory: FDA pending
Meta: Onc.AI leverages deep learning and a vast oncology dataset to predict clinical outcomes in lung cancer, aiding treatment decisions and pharma development.
Content: [![Onc.ai Logo](https://onc.ai/wp-content/uploads/2021/11/oncai_logo_updated-color-2.png)](https://onc.ai/) - [About](https://onc.ai/#about) - [Pharma AI](https://onc.ai/pharma-clinical-ai/) - [Clinical AI](https://onc.ai/pharma-clinical-ai#module-5) - [News](https://onc.ai/#news) - [Contact](https://onc.ai/#contact) ![](https://onc.ai/) [Learn More](https://onc.ai/#) Your browser does not support the video tag. # Seeing Through Cancer Deep Learning imaging AI to bring clarity to cancer treatment decision-making [Join Our Team](https://onc.ai/open-roles/) ## Our Company ### Onc.AI is a privately held digital health company on a mission to radically improve oncology decision making By leveraging a market-leading oncology real-world dataset (diagnostic imaging, EMR, labs, genomics), Onc.AI is developing a pipeline of AI models to fulfill the potential of precision oncology. Our first products predict clinical outcomes in metastatic lung cancer to inform pharma clinical development and medical oncologist decision-making (FDA pending) ## Our Investors and Partners [![](https://onc.ai/wp-content/uploads/2023/01/bluefund1.png)![](https://onc.ai/wp-content/uploads/2023/01/bluefund2.png)](https://blueventurefund.com/) [![](https://onc.ai/wp-content/uploads/2023/01/massmutual1.png)![](https://onc.ai/wp-content/uploads/2023/01/massmutual2.png)](https://www.massmutual.com/) [![](https://onc.ai/wp-content/uploads/2023/01/action1-1.png)![](https://onc.ai/wp-content/uploads/2023/01/action2-1.png)](https://www.actionpotentialvc.com/) [![](https://onc.ai/wp-content/uploads/2023/01/accomplice1.png)![](https://onc.ai/wp-content/uploads/2023/01/accomplice2.png)](https://accomplice.co/) [![](https://onc.ai/wp-content/uploads/2023/01/digitalis1.png)![](https://onc.ai/wp-content/uploads/2023/01/digitalis2.png)](https://digitalisventures.com/) [![](https://onc.ai/wp-content/uploads/2023/01/lifex1.png)![](https://onc.ai/wp-content/uploads/2023/01/lifex2.png)](https://www.lifex.vc/) [![](https://onc.ai/wp-content/uploads/2023/01/kdt1.png)![](https://onc.ai/wp-content/uploads/2023/01/kdt2.png)](https://www.kdtvc.com/) [![](https://onc.ai/wp-content/uploads/2023/01/svb1-1.png)![](https://onc.ai/wp-content/uploads/2023/01/svb2-1.png)](https://www.svb.com/#) [![](https://onc.ai/wp-content/uploads/2025/05/NIH-Logo_Grey.png)![](https://onc.ai/wp-content/uploads/2025/05/NIH-Logo_FullColor.png)](https://www.cancer.gov/) ## Latest News ![](https://onc.ai/wp-content/themes/onc-ai-theme/assets/img/arrow-left.svg) ![](https://onc.ai/wp-content/uploads/2025/07/pintad-logo.png) July 2025 ## [Talk at The Pharma Imaging Network for Therapeutics and Diagnostics (PINTaD) – Advancing Oncology Imaging Beyond RECIST 1.1](https://app.box.com/s/a2qqwfqf880ukvefccntnkylbh39rh48) [Read More ![right arrow icon](https://onc.ai/wp-content/themes/onc-ai-theme/assets/img/carrot-right.svg)](https://app.box.com/s/a2qqwfqf880ukvefccntnkylbh39rh48) ![](https://onc.ai/wp-content/uploads/2023/06/business-w

Onc.AI leverages deep learning and a vast oncology dataset to predict clinical outcomes in lung cancer, aiding treatment decisions and pharma development.

Onc.AI

Onc.AI utilizes a comprehensive oncology dataset, including diagnostic imaging, EMR, labs, and genomics, to develop AI models aimed at advancing precision oncology. Their initial focus is on predicting clinical outcomes in metastatic lung cancer, supporting both pharmaceutical clinical development and medical oncologist decision-making. The technology is designed to integrate seamlessly into existing clinical workflows, providing actionable insights to inform treatment strategies.

Onc.AI

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact